Our governance

The main decision-making, executive and managerial bodies at Medicines and Healthcare products Regulatory Agency.

Corporate governance

We’re governed by a board, which is advised by the corporate executive team (CET).

The Board

The Board is responsible for advising on the strategic development of the agency and ensuring that targets set out in the business plan and agreed with ministers are met.

The Board doesn’t have any involvement in any regulatory decisions affecting medicines or medical devices. These are the responsibility of the chief executive, working through the corporate executive team, and of the expert advisory committees.

Full details of the Board’s responsibilities can be found in our terms of reference.

Members

The Board is chaired by MHRA’s chairman, and consists of 9 non-executive directors and 2 executive members (chief executive and chief Operating Officer).

Minutes and agendas

Minutes of the agency board meetings will be provided to the corporate executive team for information and consideration. Redacted minutes and Agendas will be made available to staff and on GOV.UK.

Agendas

Agency Board agenda: 12 September 2016, public session (PDF, 120KB, 1 page)

Agency Board agenda: 11 April 2016, public session (PDF, 118KB, 1 page)

Agency Board agenda: 12 February 2016, public session (PDF, 111KB, 1 page)

Minutes

Agency Board minutes: 12 September 2016 (PDF, 422KB, 9 pages)

Agency Board minutes: 9 May 2016 (PDF, 238KB, 9 pages)

Agency Board (part two) minutes 11 April 2016 (PDF, 203KB, 5 pages)

Agency Board minutes: 11 April 2016 (PDF, 318KB, 9 pages)

Agency Board minutes 14 March 2016 (PDF, 221KB, 6 pages)

Agency Board minutes (part two) 12 February 2016 (PDF, 193KB, 3 pages)

Agency Board minutes: 12 February 2016 (PDF, 177KB, 5 pages)

Agency Board minutes: 9 December 2015 (PDF, 40.1KB, 5 pages)

Agency Board minutes: 20 November 2015 (PDF, 45.3KB, 6 pages)

Agency Board minutes: 16 October 2015 (PDF, 217KB, 6 pages)

Agency Board minutes: 18 September 2015 (PDF, 52.6KB, 7 pages)

Agency Board minutes: 16 July 2015 (MS Word Document, 47.1KB)

Agency Board minutes: 22 June 2015 (PDF, 214KB, 5 pages)

Agency Board minutes: 15 May 2015 (PDF, 212KB, 5 pages)

Agency Board minutes: 23 March 2015 (PDF, 223KB, 7 pages)

Agency Board minutes: 18 February 2015 (PDF, 218KB, 6 pages)

Agency Board minutes: 16 December 2014 (PDF, 212KB, 5 pages)

Agency Board minutes: 7 November 2014 (PDF, 223KB, 7 pages)

Older minutes are available on the National Archives website.

MHRA Board meeting: 12 December 2016

Agenda Part 1 - Public Session 12 December 2016 (PDF, 112KB, 1 page)

Information note - 12 December 2016 (PDF, 309KB, 1 page)

Agenda item 4: Minutes of September board public session (PDF, 421KB, 9 pages)

Agenda item 8: Talent Management Initiative update (PDF, 105KB, 5 pages)

Agenda item 9: Apprenticeships update (PDF, 103KB, 4 pages)

Agenda item 10: NIBSC highlights (PDF, 164KB, 6 pages)

If you are interested in attending, please email: directorate@mhra.gsi.gov.uk by 5.00 pm on Monday, 5 December to register.

MHRA Board meeting: 12 September 2016

Agency Board agenda: 12 September 2016, public session (PDF, 120KB, 1 page)

Information note for MHRA’s 12 September board meeting (in public session) (PDF, 309KB, 1 page)

Agenda item 4 :Minutes of the Board meeting – public session11 April 2016 (PDF, 61.9KB, 9 pages)

Agenda item 7: CEO's Report (PDF, 109KB, 13 pages)

Agenda item 8: Strategic Direction for Medicines Information (PDF, 232KB, 12 pages)

Agenda item 9: YC Collaboration with the National Poisons Information Service (PDF, 59.4KB, 11 pages)

Agenda item 10: Working with the Devolved Administrations (PDF, 30.9KB, 7 pages)

Agenda item 11: People Strategy 2014-2019 (refreshed 2016) (PDF, 78KB, 17 pages)

Agenda item 12: Finance & Procurement Monthly Report (PDF, 1.69MB, 14 pages)

Agenda item 13: Quarterly report – BP Monitoring Report Q1 2016-17 (PDF, 185KB, 4 pages)

Quarterly report – BP Monitoring Report - Annex A (PDF, 228KB, 3 pages)

Quarterly report – BP Monitoring Report - Annex B (PDF, 277KB, 7 pages)

Quarterly report – BP Monitoring Report - Annex C (PDF, 42.8KB, 3 pages)

Quarterly report – BP Monitoring Report - Annex D (PDF, 89.5KB, 1 page)

MHRA Board meeting: 11 April 2016

MHRA Board meeting 11 April 2016 (PDF, 118KB, 1 page)

Information note for MHRA’s board meeting (in public session) (PDF, 308KB, 1 page)

Minutes of public board meeting of 12 February 2016 (PDF, 42KB, 4 pages)

Item 6: CEO's report (PDF, 415KB, 13 pages)

Item 7: Innovation office - questions from the public (PDF, 392KB, 6 pages)

Item 8: Joint patient safety and vigilance strategy (PDF, 195KB, 10 pages)

Item 9: People survey report (PDF, 167KB, 3 pages)

Item 9: People survey report (PDF, 537KB, 1 page)

Item 10: Digital information management - Annex A (PDF, 318KB, 9 pages)

Item 10: Digital information management (PDF, 114KB, 6 pages)

Item 11: Budget 2016 - 2017 (PDF, 692KB, 31 pages)

Item 12: Finance and Procurement report (PDF, 3.17MB, 32 pages)

Item 13: Note of March 2015 ARAC meeting (PDF, 400KB, 12 pages)

Glossary- Commonly used words, phrases and abbreviations (PDF, 267KB, 30 pages)

MHRA Board meeting: 12 February 2016

You can download papers from the 12 February 2016 Board Meeting in our filecamp folder.

Corporate executive team

The corporate executive team (CET) - previously the executive board - is the highest executive decision-making body of the agency. The CET is chaired by the chief executive, Dr Ian Hudson, and is made up of:

  • the directors of each of MHRA’s divisions
  • the director of the National Institute for Biological Standards and Control
  • the director of the Clinical Practice Research Database
  • a representative from the Department of Health Legal Services

The CET has overall responsibility for:

  • day-to-day management
  • strategic decision-making
  • line management
  • all financial, policy, operational and resource management issues

Full details of the CET’s responsibilities can be found in our terms of reference.

Minutes

CET minutes: 04 November 2015 (PDF, 187KB, 7 pages)

CET minutes: 13 October 2015 (PDF, 228KB, 7 pages)

CET minutes: 15 September 2015 (PDF, 146KB, 6 pages)

CET minutes: 11 August 2015 (PDF, 203KB, 6 pages)

CET minutes: 14 July 2015 (PDF, 286KB, 7 pages)

See minutes of meetings 13 January 2015 - 19 June 2015

Older minutes are available on the National Archives website.

Conflicts of interest between our 3 constituent groups

The work carried out by MHRA, the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD) is closely linked. Since our merger we know that some of the work NIBSC and CPRD do may need to be regulated by MHRA. We know that this is a potential conflict of interest because of our close relationship. To help deal with these situations, we have produced a: